Your browser doesn't support javascript.
loading
The discovery of a selective and potent A2a agonist with extended lung retention.
Åstrand, Annika B M; Lamm Bergström, Eva; Zhang, Hui; Börjesson, Lena; Söderdahl, Therese; Wingren, Cecilia; Jansson, Anne-Helene; Smailagic, Amir; Johansson, Camilla; Bladh, Håkan; Shamovsky, Igor; Tunek, Anders; Drmota, Tomas.
Afiliação
  • Åstrand AB; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Lamm Bergström E; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Zhang H; Drug Safety & Metabolism, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Börjesson L; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Söderdahl T; Drug Safety & Metabolism, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Wingren C; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Jansson AH; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Smailagic A; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Johansson C; Drug Safety & Metabolism, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Bladh H; AstraZeneca R&D Lund SE-221 87, Lund, Sweden.
  • Shamovsky I; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Tunek A; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
  • Drmota T; RIA iMed, AstraZeneca R&D Mölndal SE-431 59, Mölndal, Sweden.
Pharmacol Res Perspect ; 3(3): e00134, 2015 Jun.
Article em En | MEDLINE | ID: mdl-26236482

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article